Alprostadil Liposomes (Yipinhong Pharmaceutical)

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameAlprostadil Liposomes (Yipinhong Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > LipidSmall molecules
Mechanisms of ActionProstaglandin agonists
TargetsProstaglandin
Therapy Area/IndicationsArteriosclerosis Obliterans
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesGuangzhou Yipinhong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGuangzhou Yipinhong Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsArteriosclerosis Obliterans

Other Information

ATC CodeN/A
Related LinksN/A